Skip to main content
TMO logo

Thermo Fisher Scientific Inc.

TMONYSEHealthcareDiagnostics & Research

$684.89Today:- (-)1Y +18.29%

As of Oct 26, 2026 close

Market cap
$254.09B
P/E (TTM)
36.41
Forward P/E
34.28
Dividend yield
0.27%
52-week range
$435.27$704.00
Volume (live)
-
Avg. volume (3M)
2.49M

Thermo Fisher Scientific (TMO) Income Statement

Thermo Fisher Scientific reported revenue of $44.56B in fiscal 2025 (fiscal year ended Dec 31, 2025), up 3.9% from $42.88B a year earlier. Net income was $6.74B, up 6.3% year over year, a net margin of 15.1%. Gross margin was 40.9% and operating margin 18.2%. In the most recent quarter, Q3 fiscal 2026 (ended Sep 26, 2026), revenue was $12.14B, up 9.1% from the same quarter a year earlier.

Thermo Fisher Scientific Income Statement Analysis

Values in billions USD

Scroll to see more
Thermo Fisher Scientific Inc. income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue44.5642.8842.8644.9239.2132.2225.5424.3620.92
Cost of Revenue26.3225.1825.6625.9019.5716.1914.2013.3711.24
Gross Profit18.2417.7017.1919.0119.6416.0311.3410.999.68
Operating Expenses
Research & Development1.401.391.341.471.411.181.000.970.89
Selling, General & Administrative8.738.608.419.027.866.956.066.035.41
Operating Expenses10.139.999.7510.499.618.137.097.126.41
Operating Income8.117.727.458.5310.037.904.263.873.27
Other Income/Expense
Interest Income0.991.080.880.270.040.070.220.140.08
Interest Expense1.421.391.490.73-0.540.550.680.670.59
Other Income/Expense-0.84-0.37-1.21-0.86-1.19-0.67-0.19-0.61-0.84
Income
Income Before Tax7.277.046.247.668.847.234.073.262.43
Income Tax Expense0.550.660.280.701.110.850.370.320.20
Net Income6.746.346.006.957.736.383.702.942.23
Net Income - Continuous Operations6.746.346.006.957.736.383.702.942.23
Net Income - Discontinued Operations---------
EBITDA11.4711.5411.2011.9412.9610.117.026.205.05
EBIT8.738.437.678.5610.37----
Depreciation & Amortization2.783.113.413.382.592.332.282.272.03
Earnings Per Share
Basic EPS18.0017.0016.0018.0020.0016.009.007.006.00
Diluted EPS18.0017.0015.0018.0019.0016.009.007.006.00
Basic Shares Outstanding0.380.380.390.390.390.400.400.400.40
Diluted Shares Outstanding0.380.380.390.390.400.400.400.410.40

Source: Company financial statements from annual and quarterly filings. Data as of Sep 26, 2026. Data sources and methodology

Frequently Asked Questions About Thermo Fisher Scientific Financial Statements

What was Thermo Fisher Scientific's revenue in fiscal 2025?

Thermo Fisher Scientific reported revenue of $44.56B in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 3.9% from $42.88B a year earlier.

Is Thermo Fisher Scientific profitable?

Yes. Thermo Fisher Scientific earned net income of $6.74B in fiscal 2025, a net margin of 15.1%. In fiscal 2024 it earned $6.33B.

What is Thermo Fisher Scientific's operating margin?

Thermo Fisher Scientific's operating income was $8.11B on revenue of $44.56B in fiscal 2025, an operating margin of 18.2%, compared with 18.0% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition